Masimo Corporation $MASI Shares Bought by Geode Capital Management LLC

Geode Capital Management LLC raised its position in Masimo Corporation (NASDAQ:MASI) by 1.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 953,976 shares of the medical equipment provider’s stock after purchasing an additional 11,537 shares during the quarter. Geode Capital Management LLC owned about 1.78% of Masimo worth $124,096,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in MASI. Global Retirement Partners LLC acquired a new stake in shares of Masimo in the fourth quarter valued at approximately $27,000. Torren Management LLC acquired a new stake in shares of Masimo in the fourth quarter valued at approximately $35,000. Smartleaf Asset Management LLC increased its stake in shares of Masimo by 80.0% in the third quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 136 shares during the period. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Masimo in the fourth quarter valued at approximately $44,000. Finally, Advisory Services Network LLC acquired a new stake in shares of Masimo in the third quarter valued at approximately $46,000. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Trading Down 0.0%

Masimo stock opened at $178.82 on Friday. The firm has a 50 day simple moving average of $178.45 and a 200-day simple moving average of $159.32. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.45. The stock has a market capitalization of $9.36 billion, a PE ratio of -16.97, a price-to-earnings-growth ratio of 1.81 and a beta of 1.11. Masimo Corporation has a 12-month low of $125.94 and a 12-month high of $179.00.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on MASI shares. Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. BTIG Research lowered shares of Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. Wolfe Research lowered shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 19th. Stifel Nicolaus set a $180.00 price target on shares of Masimo in a research note on Tuesday, February 17th. Finally, Piper Sandler cut shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price objective for the company. in a report on Tuesday, February 17th. Nine investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $180.40.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.